Featured Article
Women in labor can now be tested more specifically for risk of preeclampsia using the ratio of two blood proteins, fibrinogen and albumin (FAR).
Precision Oncology Today
Magazine
5 Key Startups Bringing Digital Pathology Into Focus
Digital pathology is driving precision medicine by turbocharging the analysis of tissue slides. Here are the five top startups turning microscopy into a data...
How Is Artificial Intelligence Changing the Clinical Trials Landscape?
There is no doubt that artificial intelligence (AI) is currently en vogue. Many AI and machine-learning applications are already being deployed in drug discovery and development. Not only can AI process, analyze, and interpret huge datasets, it can also be used for structural drug design and toxicity and efficacy predictions.
Trending on Inside Precision Medicine
On/Off Switch for CAR-T Cell Therapy Shows Early Promise
Researchers have developed a new CAR-T cell cancer therapy that can be switched on and off using oral medicines that are already approved.
There’s Now a Better Test to Detect Preeclampsia Risk
Women in labor can now be tested more specifically for risk of preeclampsia using the ratio of two blood proteins, fibrinogen and albumin (FAR).
AI-Enabled Wearable Cameras Could Serve as Critical Safeguards Against Medication Errors in Hospitals
The system, designed to be used in environments such as operating rooms and intensive care units, demonstrated a high level of accuracy, achieving 99.6% sensitivity and 98.8% specificity in identifying vial-swap errors.
